STIM · Neuronetics, Inc.
$3.30
+0.27 (+8.91%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Should the lender call the facility, the Company is not projected to have the liquidity required to meet its requirement to pay off the loan. Therefore, substantial doubt exists about the Company's ability to continue as a going concern. Actions within the Company's control to meet its minimum revenue covenant include improvements to its revenue cycle management, introducing new treatment options at its clinic locations and pursuing new strategies within its NeuroStar business to accelerate sales growth and optimize its product mix. The Company's ability to meet its liquidity needs, including meeting future revenue and liquidity covenants, is dependent on growth in existing and acquired product and service lines and the realization of synergies related to its acquisition of Greenbrook. However, at this time, these actions do not fully mitigate the risk related to compliance with the revenue covenant for the March 31, 2027 period.”View the 10-Q filed Aug 11, 2026
Market Cap
$251.45M
Shares
76.20M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$149.16M
+99.2%
FY2025
Net Income
-$39M
+10.8%
FY2025
Gross Margin
48.48%
-23.8pp
FY2025
Operating Margin
-21.08%
+25.1pp
FY2025
Diluted EPS
-$0.59
+57.2%
FY2025
Operating Cash Flow
-$20.4M
+34.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $160M – $164M | $155.1M | $149.16M | $74.89M | $71.35M | $65.21M | $55.31M | $49.24M | $62.66M | $52.78M | $40.43M | $34.23M | |
| — | $230K | $200K | $100K | $200K | $200K | $300K | $400K | $700K | $900K | $1.1M | — | |
| — | $78.91M | $76.85M | $20.73M | $19.64M | $15.48M | $11.65M | $11.55M | $15.39M | $12.45M | $9.63M | $6.62M | |
| — | $76.19M | $72.31M | $54.16M | $51.71M | $49.72M | $43.66M | $37.69M | $47.27M | $40.33M | $30.8M | $27.61M | |
| — | — | 48.48% | 72.32% | 72.47% | 76.26% | 78.93% | 76.54% | 75.44% | 76.42% | 76.18% | 80.65% | |
| — | $5.87M | $6.58M | $12.77M | $9.52M | $9.34M | $7.92M | $9.2M | $13.75M | $8.23M | $7.94M | $8.22M | |
| — | $44.31M | $47.46M | $45.63M | $47.32M | $49.98M | $37.75M | $32.56M | $42.99M | $38.26M | $27.9M | $21.79M | |
| — | $48.87M | $49.7M | $30.32M | $25.43M | $25.52M | $25.55M | $18.24M | $17.46M | $13.67M | $8.57M | $6.93M | |
| — | $1.5M | $1.5M | $100K | — | — | — | — | — | — | — | — | |
| — | $3.2M | $3.47M | $2.07M | $2.01M | $1.65M | $1.06M | $941K | $1.07M | $882K | $596K | $673K | |
| — | $99.05M | $103.74M | $88.72M | $82.26M | $84.83M | $71.22M | $60M | $74.2M | $60.16M | $44.41M | $36.94M | |
| — | -$22.86M | -$31.44M | -$34.56M | -$30.55M | -$35.11M | -$27.56M | -$22.31M | -$26.93M | -$19.83M | -$13.61M | -$9.34M | |
| — | — | -21.08% | -46.15% | -42.82% | -53.85% | -49.83% | -45.3% | -42.98% | -37.58% | -33.66% | -27.28% | |
| — | -$19.66M | -$27.97M | -$32.49M | -$28.55M | -$33.46M | -$26.5M | -$21.37M | -$25.87M | -$18.95M | -$13.01M | -$8.66M | |
| — | $8.92M | $8.42M | $7.29M | $5.42M | $4.25M | $4.02M | $4.52M | $3.69M | $3.69M | $2.81M | $1.84M | |
| — | $1.46M | $716K | $2.55M | $5.79M | $2.2M | $390K | $302K | $1.57M | -$575K | $357K | -$62K | |
| — | — | — | — | — | — | — | — | -$29M | -$24.1M | -$16.1M | -$11.2M | |
| — | -$30.42M | -$39M | -$43.71M | -$30.19M | -$37.16M | -$31.19M | -$27.45M | -$29.04M | -$24.1M | -$16.06M | -$11.23M | |
| — | — | -26.15% | -58.36% | -42.31% | -56.99% | -56.39% | -55.75% | -46.35% | -45.66% | -39.72% | -32.82% | |
| — | -$419K | -$137K | -$19K | — | — | — | — | — | — | — | — | |
| USD/shares | — | — | -$0.59 | -$1.38 | -$1.05 | -$1.38 | -$1.22 | -$1.46 | -$1.58 | — | — | — |
| USD/shares | — | — | -$0.59 | -$1.38 | -$1.05 | -$1.38 | -$1.22 | -$1.46 | -$1.58 | — | — | — |
| shares | — | — | 65.95M | 31.73M | 28.66M | 26.9M | 25.48M | 18.84M | 18.38M | 8.95M | 186K | 146K |
| shares | — | — | 65.95M | 31.73M | 28.66M | 26.9M | 25.48M | 18.84M | 18.38M | 8.95M | 186K | 146K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.89×
Peer median 2.35×
EV/EBIT
—
Peer median 22.11×
P/E (TTM)
—
Peer median 31.70×
Peer medians compare against the 83 similar-size Medical Devices companies (of 148 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Clinical Services Segment | $86,977,000 | $4,445,000 | — | — |
| Medical Device Segment | $62,180,000 | $70,445,000 | $71,348,000 | $65,206,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Service | $86,977,000 | $4,445,000 | — |
| Product | $62,180,000 | $70,445,000 | $71,348,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Medical Device Segment | $3,243,000 | -$4,606,000 | -$5,128,000 | -$35,111,000 |
| Clinical Services Segment | -$3,167,000 | $365,000 | — | — |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Clinical Services Segment | -3.6% | 8.2% | — | — |
| Medical Device Segment | 5.2% | -6.5% | -7.2% | -53.8% |